Glycemic variability is associated with myocardial damage in nondiabetic patients with ST-elevation myocardial
Satoshi Oka1, Juntaro Deyama1, Ken Umetani1
1Department of Cardiology, Yamanashi Prefectural Central Hospital, Kofu, Yamanashi Prefecture, Japan.
Insights
Glycemic variability (GV) is linked to myocardial damage in non-diabetic patients post-percutaneous coronary intervention for myocardial infarction. Higher GV correlated with worse outcomes, suggesting GV is a significant factor in this patient group.
Area of Science:
- Cardiology
- Endocrinology
- Medical Research
Background:
- Glycemic variability (GV) is known to cause coronary microcirculatory disturbance and myocardial damage in diabetic patients with acute myocardial infarction.
- The association between GV and myocardial damage in non-diabetic patients with acute myocardial infarction is not well understood.
Purpose of the Study:
- To investigate the relationship between glycemic variability and myocardial damage in non-diabetic patients with ST-segment elevation myocardial infarction (STEMI).
Main Methods:
- A continuous glucose monitoring system was used to assess GV in non-diabetic STEMI patients undergoing emergent percutaneous coronary intervention.
- GV was quantified using the mean amplitude of glycemic excursions (MAGE).
- Myocardial damage was evaluated by myocardial blush grade and ST-segment resolution (STRes).
Main Results:
- The higher MAGE group exhibited significantly lower myocardial blush grade (p=0.001) and poorer ST-segment resolution (p=0.044) compared to the lower MAGE group.
- Specifically, complete STRes was less frequent in the higher MAGE group (33.3% vs. 56.8%).
- The higher MAGE group also showed a trend towards more instances of no STRes (30.6% vs. 10.8%).
Conclusions:
- Glycemic variability is associated with myocardial damage in non-diabetic patients following percutaneous coronary intervention for ST-segment elevation myocardial infarction.
- These findings highlight the importance of managing GV in this patient population to potentially improve cardiac outcomes.
Background:
Glycemic variability (GV) induces coronary microcirculatory disturbance and myocardial damage in diabetic patients with acute myocardial infarction. However, in nondiabetic acute myocardial infarction patients, the relationship between GV and myocardial damage remains unclear.
Patients And Methods:
We investigated GV with a continuous glucose monitoring system in nondiabetic ST-segment elevation myocardial infarction patients treated with emergent percutaneous coronary intervention. GV was expressed as the mean amplitude of glycemic excursions (MAGE). Myocardial damage was estimated by myocardial blush grade and ST-segment resolution (STRes). STRes was defined as complete (>70%), partial (30-70%), or none (<30%).
Results:
Consecutive patients (n=73) were enrolled and classified into a lower or higher MAGE group on the basis of the median MAGE. The higher MAGE group showed lower levels of myocardial blush grade (2.41±0.76 vs. 1.72±0.85, P=0.001) and STRes (complete: 56.8 vs. 33.3%, P=0.044; partial: 32.4 vs. 36.1%, P=0.741; none: 10.8 vs. 30.6%, P=0.037).
Conclusion:
GV was associated with myocardial damage after percutaneous coronary intervention in nondiabetic ST-segment elevation myocardial infarction patients.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis I: Introduction
Myocarditis III: Medical Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...


